AI & Data · Week of Nov 2, 2026
Investor updates and AI integrations: the week in AI & Data
Earnings updates, shareholder letters and a governance dispute sat alongside AI product integrations and a Docusign procurement acquisition.
Much of the week's news came from companies addressing investors directly. Clarivate reported third-quarter results and updated its outlook after selling its Life Sciences & Healthcare segment, Robo.ai published a CEO letter as split-adjusted trading began, and FF EAI Robotics Ecosystem issued a weekly update on record robot shipments. At Fermi, co-founder Toby Neugebauer issued a statement on the annual meeting results and called for the company to be put up for sale.
On the product side, companies continued attaching AI capabilities to existing platforms. Research Solutions connected Scite and Article Galaxy to Microsoft Copilot, Docusign acquired procurement intelligence company Suplari to pair with its Iris AI engine, and Eva Live launched an AI-powered crypto trading platform. DataMEDS AI announced a peptide supply agreement through its Corexa Health subsidiary.
Clarivate Plc
Clarivate Reports Third Quarter 2026 Results, Delivering Clear Path to Value Creation
Clarivate reported third quarter 2026 total revenues of $567.9 million including LS&H, against $623.1 million a year earlier, and a net loss of $80.8 million that it says was driven by a $62.2 million non-cash goodwill impairment. It completed the LS&H sale on October 6, 2026 for net cash proceeds of $488.4 million and set 2026 continuing-operations revenue guidance of $1.965B to $1.985B.
FF EAI Robotics Ecosystem Inc.
FF EAI Robotics Ecosystem (FFR) CEO YT Jia Shares Weekly Investor Update: Recaps FFR's Listing Closing and First Investor Day in New York; FFR Sold and Shipped 351 Robot Devices in October, Setting Another Monthly Record
FF EAI Robotics Ecosystem says it sold and shipped 351 robot devices in October, which it calls a monthly record, bringing the cumulative total since the end of February to 1,168 units. The company says it expects more than 400 units per month in November and December, toward full-year guidance of approximately 2,000 devices for the acquired robotics business.
Toby Neugebauer
Fermi's Co-Founder and Largest Shareholder, Toby Neugebauer: "Fermi's Shareholders, the Markets and Texas Voters Have Rejected Rick Perry and Fermi's 'We Can Do Whatever We Want' Board"
Fermi co-founder Toby Neugebauer says only 38.9% of outstanding shares voted to re-elect Rick Perry, and that an August 11 bylaw change adopted without a shareholder vote cost Perry the election. Neugebauer is calling on Fermi to put the company up for sale while closing a tenant deal, and says discovery in his lawsuit is underway.
Robo.ai Inc.
Robo.ai CEO Issues Letter to Shareholders
Robo.ai CEO Benjamin Zhai's letter says revenue exceeded US$280 million for June through September and reiterates a preliminary full-year 2026 outlook of approximately US$600 million. The company says it does not intend to enter into new equity-linked, variable-price financing arrangements for a period following the letter, as split-adjusted trading began on Nasdaq on November 6.
Research Solutions, Inc.
Research Solutions Brings Scite & Article Galaxy To Microsoft Copilot
Research Solutions has integrated its Scite and Article Galaxy products with Microsoft Copilot, both available now in the Microsoft Marketplace. The company says Microsoft 365 users can now search scientific literature and check access rights and pricing without leaving Microsoft 365, extending its strategy of linking Scite to tools such as ChatGPT, Claude and other MCP-enabled tools.
Docusign, Inc.
Docusign Acquires Suplari to Accelerate AI-Powered Contract Management for Procurement
Docusign has acquired Seattle-based procurement intelligence company Suplari for undisclosed terms and plans to combine its technology with the Iris AI engine on the Docusign IAM platform. Docusign says the combination is intended to help procurement teams identify savings, track supplier obligations, inform renewals and flag risks.
Eva Live Inc
Eva Live Launches EvaXCrypto, an AI-Powered Cryptocurrency Trading Software Platform
Eva Live launched EvaXCrypto, an AI-powered platform that executes cryptocurrency trades automatically through users' own accounts at nine third-party exchanges, including Kraken, Coinbase Advanced and Robinhood Crypto. The company says the platform does not hold or custody user funds and that the launch does not change its treasury policy.
DataMEDS AI, Inc.
DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee
DataMEDS AI subsidiary Corexa Health has entered a commercial supply agreement for six peptides recommended by the FDA's Pharmacy Compounding Advisory Committee, including BPC-157 and TB-500. Corexa Pharmacy intends to begin dispensing compounded prescriptions in November 2026, and the company notes the peptides are not FDA-approved.
This roundup is written with AI assistance from the press releases listed above, using only what they state. The releases are the companies' own announcements, not Robot Hate reporting.